Related Experiment Video
Updated: Aug 8, 2026

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
Published on: June 15, 2011
Serotonin and thrombotic complications
1Department of Internal Medicine, University of Texas Medical School, Houston.
Insights
Unstable angina and myocardial infarction stem from platelet aggregation and vasoconstriction due to thromboxane and serotonin at coronary artery blockages. These processes can lead to blood clots and heart muscle damage.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Thrombosis
Background:
- Coronary artery disease progression can lead to acute cardiac events.
- Understanding the mechanisms of plaque rupture and thrombosis is crucial.
Purpose of the Study:
- To elucidate the pathophysiological continuum from chronic stable angina to acute myocardial infarction.
- To explore the roles of platelet aggregation and vasoconstriction in acute coronary syndromes.
Main Methods:
- The study is based on a theoretical model and existing literature review.
- It synthesizes evidence on the biochemical and cellular processes involved in coronary artery thrombosis.
Main Results:
- Progressive platelet aggregation and dynamic vasoconstriction, driven by thromboxane and serotonin, are implicated in myocardial ischemia.
- Imbalances between pro-thrombotic and vasodilatory factors contribute to coronary artery obstruction.
- The duration of coronary obstruction determines the severity of myocardial infarction, from non-Q-wave to Q-wave.
Conclusions:
- Unstable angina and acute myocardial infarction represent a continuum of coronary artery thrombosis and vasoconstriction.
- Local biochemical changes at sites of stenosis and endothelial injury are key drivers.
- These mechanisms can lead to myocardial necrosis, electrical instability, and sudden death.
Abstract:
We believe that the abrupt conversion from chronic stable to unstable angina and the continuum to acute myocardial infarction may result from myocardial ischemia caused by progressive platelet aggregation and dynamic vasoconstriction themselves caused by local increases in thromboxane and serotonin at sites of coronary artery stenosis and endothelial injury. Platelet aggregation and dynamic coronary artery vasoconstriction probably result from the local accumulation of thromboxane and serotonin and also relative decreases in the local concentrations of endothelially derived vasodilators and inhibitors of platelet aggregation, such as endothelium-derived relaxing factor (EDRF) and prostacyclin. With severe reductions in coronary blood flow caused by these mechanisms, platelet aggregates may increase, and an occlusive thrombus composed of platelets and white and red blood cells in a fibrin mesh may develop. When coronary arteries are occluded or narrowed for a sufficient period of time by these mechanisms, myocardial necrosis, electrical instability, or sudden death may occur. We believe that unstable angina and acute myocardial infarction are a continuum in relation to the process of coronary artery thrombosis and vasoconstriction. When the period of platelet aggregation or dynamic vasoconstriction at sites of endothelial injury and coronary artery stenosis is brief, unstable angina or non-Q-wave infarction may occur. However, when the coronary artery obstruction by these mechanisms is prolonged for several hours. Q-wave myocardial infarction results. Chronic endothelial injury and coronary artery stenosis are probably associated with the accumulation of platelets, white and red blood cells, and a fibrin mesh at the site of stenosis and endothelial injury.(ABSTRACT TRUNCATED AT 250 WORDS)
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke ll: Pathophysiology

